PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsPDI Professional Disposables International
PDI Professional Disposables International
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
HexascrubHexachlorophene1982-01-01
Acne vulgaris
,
Communicable diseases
Prevantics maxi swabstickFenofibrate, Chlorhexidine2005-06-032024-2033
Hypercholesterolemia
,
Coronary artery disease
,
Dyslipidemias
,
Hypertriglyceridemia
,
Hyperlipoproteinemias
,
Periodontal diseases
,
Infectious skin diseases
,
Gram-negative bacterial infections
,
Oral candidiasis
,
Gram-positive bacterial infections
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Fenofibrate
preoperative care
,
infections
,
communicable diseases
Chlorhexidine gluconate
infections
,
healthy volunteers/patients
,
catheterization
,
communicable diseases
,
hand hygiene
,
skin diseases
,
tissue adhesions
,
ventilator-associated pneumonia
,
wounds and injuries
,
sepsis
Hexachlorophene
covid-19
,
drug-related side effects and adverse reactions
,
infections
,
communicable diseases
,
surgical wound infection
,
respiratory tract diseases
,
respiration disorders
,
staphylococcal infections
Chlorhexidine
surgical wound infection
Riboprine
depression
,
cardiovascular diseases
,
myocardial infarction
,
drug resistance
,
heat stress disorders
,
mood disorders
,
combat disorders
,
traumatic stress disorders
,
sickle cell anemia
,
inflammation
,
beta-thalassemia
,
thalassemia
,
sickle cell trait
,
heart failure
,
hypertriglyceridemia
,
hiv infections
,
liver diseases
,
non-alcoholic fatty liver disease
,
fatty liver
,
wasting syndrome
,
cachexia
,
atrial fibrillation
,
depressive disorder
Iodopovidone
covid-19
,
drug-related side effects and adverse reactions
,
infections
,
communicable diseases
,
surgical wound infection
,
respiratory tract diseases
,
respiration disorders
,
staphylococcal infections
Chloraprep
tissue adhesions
,
healthy volunteers/patients
,
infections
Corsodyl
catheterization
,
infections
,
communicable diseases
,
hand hygiene
,
skin diseases
,
healthy volunteers/patients
,
ventilator-associated pneumonia
,
wounds and injuries
,
sepsis
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use